Tekla Life Sciences Investors (HQL) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Tekla Life Sciences Inves...

    NYSE: HQL · Real-Time Price · USD
    16.46
    0.25 (1.54%)
    At close: Oct 15, 2025, 3:59 PM
    16.45
    -0.06%
    After-hours: Oct 15, 2025, 06:21 PM EDT

    Tekla Life Sciences Investors Income Statement

    Financials in USD. Fiscal year is October - September.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined.

    Fiscal Year Q2 2025 Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
    Period Ending Mar 31, 2025 Sep 30, 2024 Mar 31, 2024 Sep 30, 2023 Mar 31, 2023 Sep 30, 2022 Mar 31, 2022 Sep 30, 2021 Mar 31, 2021
    Revenue
    		 20.11M 3.98M 31.63M 31.49M 23.62M 31.86M 26.15M 45.01M 45.53M
    Cost of Revenue
    		 5.35M 5.36M 5.12M 2.59M 2.64M 5.55M 6.01M 6.08M 5.69M
    Gross Profit
    		 1.91M 3.98M 29.04M 28.9M 20.98M 26.31M 20.14M 38.94M 39.84M
    Operating Income
    		 -48.5M -1.92M -12.1M -12.39M -29.25M -104.61M -43.33M 64.53M 124.43M
    Interest Income
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Pretax Income
    		 -12.19M 85.3M 38.81M 22.35M 5.5M -104.6M -43.31M 64.53M 124.41M
    Net Income
    		 -12.19M 85.3M 38.81M 22.35M 5.5M -104.6M -43.31M 64.53M 124.41M
    Selling & General & Admin
    		 3.18M 5.9M 751.72K 903.14K 4.31M 1.44M 3.21K 3.21K 3K
    Research & Development
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Expenses
    		 n/a n/a 40.39M 40.39M -47.35M -47.35M n/a n/a n/a
    Operating Expenses
    		 3.18M 5.9M 41.14M 41.29M 17.82M 14.98M 54.77K 31.12K 61.04K
    Interest Expense
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 16.49K 24.61K 8.11K n/a n/a n/a n/a n/a n/a
    Cost & Expenses
    		 68.61M 5.9M 43.73M 43.88M 52.87M 136.47M 69.48M -19.51M -78.9M
    Income Tax Expense
    		 n/a n/a -43.81K -43.81K n/a -843.92 -1.9K -2.07K -1.84K
    Shares Outstanding (Basic)
    		 28.87M 28.77M 27.35M 26.79M 26.21M 25.68M 25.14M 24.67M 24.28M
    Shares Outstanding (Diluted)
    		 28.87M 28.77M 27.35M 26.79M 26.21M 25.68M 25.14M 24.67M 24.28M
    EPS (Basic)
    		 -0.42 3.06 1.41 0.86 0.19 -4.13 -1.69 2.64 5.21
    EPS (Diluted)
    		 -0.42 3.06 1.41 0.86 0.19 -4.13 -1.69 2.64 5.21
    EBITDA
    		 -47.23M 100.51M 89.07M -11.45M -28.31M -104.61M -43.33M 64.53M 124.43M
    EBIT
    		 -48.5M 99.25M 89.07M -12.39M -29.25M -104.61M -43.33M 64.53M 124.43M
    Depreciation & Amortization
    		 1.27M 1.92M 697.15K 984.56K 1.59M 651.98K 1.9K 2.07K 1.84K
    Source: Financial Modeling Prep. Financial Sources.
    SEC Filings: 10-K · 10-Q

    Add to Watchlist